Population pharmacokinetics of bevacizumab in cancer patients with external validation
Crossref DOI link: https://doi.org/10.1007/s00280-016-3079-6
Published Online: 2016-06-21
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, Kelong
Peyret, Thomas
Marchand, Mathilde
Quartino, Angelica
Gosselin, Nathalie H.
Girish, Sandhya
Allison, David E.
Jin, Jin
License valid from 2016-06-21